TOCQUEVILLE ASSET MANAGEMENT L.P.
Position in IONS — Ionis Pharmaceuticals Inc
CIK 883961
New York, NY
Position in IONS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$19,918,837
+$3,457,608 QoQ
Shares Held
251,215
+14.6% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#82
of 510 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Derivatives in IONS
reported options exposure · as of Jun 30, 2026CallValue
$79,290
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026TOCQUEVILLE ASSET MANAGEMENT L.P. holds $29,586,127 across 12 Biotechnology names. IONS ranks #1 (67.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
This page
|
251,215 | $19,918,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,315 | $2,067,035 | |
| 3 | CSBR |
Champions Oncology, Inc.
|
295,658 | $1,821,253 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
19,650 | $1,463,532 | |
| 5 | MGTX |
MeiraGTx Holdings plc
|
77,700 | $1,049,727 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
31,250 | $1,043,437 | |
| 7 | IMMX |
Immix Biopharma, Inc.
|
88,550 | $912,950 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
2,300 | $562,971 |
All Filings in IONS
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $79,290 | 1,000 | Call | Sole | 2026-08-10 | |
| 2026-06-30 | $19,918,837 | 251,215 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $16,461,229 | 219,220 | Shares | Sole | 2026-05-12 | |
| 2026-03-31 | $75,090 | 1,000 | Call | Sole | 2026-05-12 | |
| 2025-12-31 | $16,117,080 | 203,730 | Shares | Sole | 2026-02-12 | |
| 2025-12-31 | $79,110 | 1,000 | Call | Sole | 2026-02-12 | |
| 2025-09-30 | $12,629,003 | 193,045 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,402,000 | 187,345 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,653,707 | 187,395 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $12,310,814 | 352,140 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $16,299,212 | 406,870 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $10,726,836 | 225,070 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $6,909,123 | 159,380 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $8,083,270 | 159,780 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $7,336,072 | 161,730 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $6,666,554 | 162,480 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,807,035 | 162,480 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $6,102,461 | 161,569 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $7,182,686 | 162,394 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $6,019,637 | 162,605 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,204,385 | 167,505 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,185,424 | 170,405 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,652,496 | 168,530 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,869,058 | 172,200 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $11,037,320 | 245,492 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $15,316,516 | 270,897 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $13,088,228 | 275,832 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $16,438,755 | 278,812 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $13,457,873 | 284,642 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||